Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Nuvation Bio to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Nuvation Bio to Present at the Jefferies London Healthcare Conference